StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)

StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report issued on Wednesday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Trading Down 2.6 %

Shares of NYSE ENZ opened at $0.71 on Wednesday. Enzo Biochem has a 12-month low of $0.68 and a 12-month high of $1.50. The stock has a 50 day simple moving average of $1.03 and a 200-day simple moving average of $1.09.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings results on Monday, December 16th. The medical research company reported ($0.05) earnings per share (EPS) for the quarter. Enzo Biochem had a negative return on equity of 11.84% and a negative net margin of 81.73%.

Institutional Trading of Enzo Biochem

A number of institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC increased its stake in shares of Enzo Biochem by 3.3% during the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after acquiring an additional 11,742 shares during the period. XTX Topco Ltd boosted its stake in Enzo Biochem by 94.5% during the 2nd quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after purchasing an additional 13,735 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Enzo Biochem by 2.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after purchasing an additional 64,417 shares during the period. Finally, BBR Partners LLC bought a new stake in shares of Enzo Biochem in the 3rd quarter worth $112,000. 36.90% of the stock is owned by institutional investors and hedge funds.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.